BioServe to Use Seegene's Tests to Detect STDs, TB in India | GenomeWeb
NEW YORK (GenomeWeb News) - BioServe said today that it has inked a partnership with Seegene to develop a detection system to diagnose a number of infectious diseases in India, BioServe said today.
 
Seegene, which is based in Seoul and maintains a US headquarters in Rockville, Md., will access BioServe's repository of Indian DNA samples to collaborate on development of a test for several sexually transmitted diseases, tuberculosis, and HIV-1 and HIV-2, BioServe said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.